Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRheumatology Physician in Boston, MA
NPI: 1053346924Primary Practice Location
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston, MA
Primary Employer
Massachusetts General Physicians Organization Inc
massgeneral.org
HQ Phone
Get M.D. John's Phone NumberMobile
Get M.D. John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MA State Medical License
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Rheumatology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 100 | 160 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 38 | 41 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 18 | 18 |
Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.
Authors: Takashi Maehara, Hamid Mattoo, Miho Ohta, Vinay Mahajan, Masafumi Moriyama, Masaki Yamauchi, Jefte Drijvers, Seiji Nakamura, John Stone, Shiv Pillai
Publication Date: 2016-01-08
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study.
Authors: Yicong Liang, Faith A Zeng, Tabrez Sheriff, Anna Wilson, Asli Bilgic, Grant Feng, John Stone, Dedee Murrell
Publication Date: 2021-09-10
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Bristol-Myers Squibb, Autoimmunity Centers of Excellence, Rho Federal Systems Division, Inc.
Intervention / Treatment: DRUG: prednisone, DRUG: acetaminophen, DRUG: methylprednisolone, DRUG: elotuzumab, DRUG: diphenhydramine, DRUG: placebo for elotuzumab, DRUG: famotidine
Lead Sponsor: Massachusetts General Hospital
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Abatacept
Lead Sponsor: Massachusetts General Hospital
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Tocilizumab, DRUG: Placebos
